Clinical Trials Directory

Trials / Completed

CompletedNCT07146399

The Impact of Ischemic Preconditioning on Exercise Performance and Physiological Function

Ischemic Preconditioning Enhances Autonomic Nervous System Modulation During Frequency Speed of Kick Test in Taekwondo Athletes: A Randomized Crossover Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Ziyue Ou · Academic / Other
Sex
Male
Age
18 Years – 22 Years
Healthy volunteers
Accepted

Summary

Ischemic Preconditioning has been confirmed to prevent long-term ischemic damage to tissues, among which the improvement of autonomic nerve system function may be one of its mechanisms of action. In recent years, IPC has gradually been applied to enhance athletic performance and accelerate postexercise recovery; however, there has been limited research on the effects of IPC on ANS function and competitive condition before and after exercise. This study investigated the effects of IPC on ANS function before and after sport-specific testing in taekwondo athletes. The objectives of our study are (1) to investigate the impact of IPC on two indicators of autonomic nervous function-HRV and HRR-and (2) to reveal the coordinating effect of IPC on the sympathetic and parasympathetic nervous systems during the warm-up phase and after specific testing in taekwondo athletes. The investigators hypothesize that IPC enhances sympathetic drive during the warm-up phase and rapidly activates the parasympathetic nervous system postexercise, which is accompanied by improvements in the athletes' competitive condition.

Conditions

Interventions

TypeNameDescription
PROCEDUREIschemic PreconditioningCompression cuff width: 10CM; Compression duration: 5min/5min (ischemia/reperfusion) \*4. 220 mmHg
PROCEDURESham (No Treatment)Compression cuff width: 10CM; Compression duration: 5min/5min (compression/relaxation) \*4. 20 mmHg

Timeline

Start date
2023-12-31
Primary completion
2024-02-07
Completion
2024-02-07
First posted
2025-08-28
Last updated
2025-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07146399. Inclusion in this directory is not an endorsement.